Glutamatergic system: Another target for the action of porphyrinogenic agents

Cellular and Molecular Biology

Volumn 55, Issue 1, 2009, Pages 23-28

  Lavandera, J V ^a   Fossati, M ^b   Azcurra, J ^b   Batlle, A ^a   Buzaleh, Ana Maria ^a,b,c  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c NONE   (Argentina)

Author keywords

Glutamatergic system; N methyl diethyl aspartate; Porphyric neuropathy; Porphyrinogenic agents

Indexed keywords

ALLYLISOPROPYLACETAMIDE; AMINOLEVULINIC ACID; GLUTAMIC ACID; ISOFLURANE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; MOUSE; NEUROPATHY; NONHUMAN; PORPHYRIA;

AMINOLEVULINIC ACID; ANIMALS; BARBITAL; CEREBELLUM; CEREBRAL CORTEX; ENFLURANE; ETHANOL; GRISEOFULVIN; ISOFLURANE; MALE; MICE; PORPHYRINOGENS; RECEPTORS, N-METHYL-D-ASPARTATE;

MUS;

EID: 67449156369     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T834     Document Type: Article

References (43)

1. Afonso, S., Rouvier Garay, V.; Martínez, M., Molinari, A., & Batlle, A. Oxidative stress induced by griseofulvine in mice liver. Biochem. Soc. Trans. 2001. 30, A72.
2. Brennan, M.J. and Cantrill, R.C., The effects of delta-aminolaevulinic acid on the uptake and efflux of amino acid neurotransmitters in rat brain synaptosomes. J. Neurochem. 1979, 33: 721-725. (Pubitemid 10235680)
3. Buzaleh, A. M., Vazquez, E. and Batlle, A., Alterations in fluorinated ether anesthetics effects on heme metabolism following chronic ethanol consumption. Gen. Pharmac. 1995. 26, 1425-1429.
4. Buzaleh, A. M., Vázquez, E., Enríquez de Salamanca, R. and Batlle, A. An overview on Anesthesia and Porphyrias (Review). Endocrinol. Metab. 1997a. 4, 267-279.
5. Buzaleh, A. M., Vazquez, E., Nuñez, G. and Batlle, A. Effect of chronic anaesthesia on drug metabolizing enzyme system and heme pathway regulation. Gen. Pharmac. 1997b. 28, 577-582. (Pubitemid 27156921)
6. Buzaleh, A. M.; Martínez, M. del C. and Batlle, A. The relevance of P-450 levels on enflurane and isoflurane action action in mice. Studies on heme pathway. Clinical and Experimental Pharmacology & Physiology 2000. 27, 796-800. (Pubitemid 30748999)
7. Carlsson, M. and Carlsson, A., Interactions between glutamatergic and monoaminergic systems within, the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci. 1990, 13: 272-276. (Pubitemid 20193457)
8. Choi, D.W., Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1: 623-634.
9. Davidson, M.D., Wilce, P. and Shanley, B.C., Increased sensitivity of the hippocampus in ethanol-dependent rats to toxic effect of N-methyl-D aspartic acid in vivo. Brain Res. 1993, 606: 5-9. (Pubitemid 23084885)
10. Demasi, M., Pellatti, C.A., DeLucia, R. and Bechara, E.J., The pro-oxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatry manifestations in porphyrias. Free Radic. Biol. Med. 1996, 20: 291-299. (Pubitemid 26077851)
11. Dodd, P.R., Beckmann, A.M., Davidson, M.S., Wilce, P.A., Glutamate-mediated transmission, alcohol, and alcoholism. Neurochem. Int. 2000, 37: 509-533. (Pubitemid 30386988)
12. Emanuelli, T., Prauchner, C.A., Dacanal, J., Zeni, A., Reis, E.C., de Mello, C.F. and de Souza, D.O., Intrastriatal administration of 5-aminolevulinic acid induces convulsions and body asymmetry through glutamatergic mechanisms. Brain Res. 2000, 868: 88-94. (Pubitemid 30332346)
13. Emanuelli, T., Pagel, F., Porciúncula, L. and Souza, D., Effect of 5-aminolevulinic acid on the glutamatergic neurotransmission. Neurochem. Int. 2003, 42: 115-121. (Pubitemid 35284780)
14. Grant, K.A., Valverius, P., Hudspith, M. and Tabakoff, B., Ethanol withdrawal seizures and the NMDA receptor complex. Eur. J. Pharmacol. 1990, 176: 289-296. (Pubitemid 20076281)
15. Gulya, K., Grant, K.A., Valverius, P., Hoffman, P.L. and Tabakoff, B., Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res. 1991, 547: 129-134.
16. Hollmann, M. and Heinemann, S., Cloned glutamate receptors. Annu. Rev. Neurosci. 1994, 17: 31-108. (Pubitemid 24117025)
17. Hu, X. and Ticku, M.K., Chronic ethanol treatment upregulates the NMDA receptor function and binding in mammalian cortical neurons. Mol. Brain Res. 1995, 30: 347-356.
18. Kalluri, H.S.G., Mehta, A.K. and Ticku, M.K., Upregulation of NMDA receptor subunits in rat brain following chronic ethanol treatment. Mol. Brain Res. 1998, 58: 221-224. (Pubitemid 28352249)
19. Kappas, A., Sassa, S., Galbraitte, R.A. and Nordmann, Y., The Porphyrias. In: The Metabolic Bases of Inherited Disease, 7th Edition, Scriver, C.R., Beaudet, A.L. and Valle, D. (eds.), McGraw Hill, New York, 1995, pp. 2103-2160.
20. Lavandera, J., Batlle, A. and Buzaleh, A.M., Metabolization of porphyrinogenic agents in brain: involvement of the Phase I drug metabolizing system. A comparative study in liver and kidney. Cel. Mol. Neurobiol. 2007, 27: 717-729. (Pubitemid 47476605)
21. Lowry, O., Rosebrough, N., Farr, A. and Randall, R., Protein measurement with the folin-phenol reagent. J. Biol. Chem. 1951, 193: 265-275.
22. Mayer, M.L. and Westbrook, G.L., The physiology of excitatory amino acids in the vertebrate central nervous system. Prog. Neurobiol. 1987, 28: 197-276. (Pubitemid 17023404)
23. McDonald, J.W. and Johnston, M.V., Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 1990, 15: 41-70. (Pubitemid 20158154)
24. McLoughlin, J.L. and Cantrill, R.C., The effect of delta-aminolaevulinic acid on the high affinity uptake of aspartic acid by rat brain synaptosomes. Gen. Pharmacol. 1984, 15: 553-555. (Pubitemid 15197586)
25. Meldrum, B. and Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 1990, 11: 379-387. (Pubitemid 20262465)
26. Meldrum, B. and Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease. In: Trends in Pharmacological Sciences: The Pharmacology of Excitatory Amino Acids, a Special Report, Lodge, D. and Collingridge, L. (eds.), Elsevier, Cambridge, UK, 1991, pp. 54-62.
27. Moriyoshi, K., Masu, M., Ishii, T., Shigemoto, R., Mizuno, N. and Nakanishi, S., Molecular cloning and characterization of the rat NMDA receptor. Nature 1991, 354: 31-37. (Pubitemid 21896774)
28. Navone, N., Buzaleh, A. M.; Polo, C., Afonso, S., Vazquez, E. and Batlle, A. The effect of griseofulvin on the heme pathway II. An exhaustive analysis during short and long-term challenge. Gen. Pharmac.1991. 22, 1179-1183.
29. Peterson, C. and Cotman, C.W., Strain-dependent decrease in glutamate binding to the N-methyl-d-aspartic acid receptor during aging. Neurosci. Lett. 1989, 104: 309-313. (Pubitemid 19231151)
30. Pierach, C.A. and Edwards, P.S., Neurotoxicity of 5-aminolevulinic acid and porphobilinogen. Exp. Neurol. 1978, 62: 810-814.
31. Puy, H., Deybach, J.C., Bogdan, A., Callebert, J., Baumgartner, M., Voisin, P., Nordmann, Y. and Touitou, Y., Increased 5-aminolevulinic acid and decreased pineal melatonin production: a common event in acute porphyria studies in the rat. J. Clin. Invest. 1996, 97: 104-110. (Pubitemid 26021699)
32. Ranft, A., Kurz, J., Deuringer, M., Haseneder, R., Dodt, H.U., Zieglgänsberger, W., Kochs, E., Eder, M. and Hapfelmeier, G., Isoflurane modulates glutamatergic and GABAergic neurotransmission in the amygdala. Eur. J. Neurosci. 2004, 20: 1276-1280. (Pubitemid 39233580)
33. Reiter, R.J., Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 1995, 9: 526-533.
34. Rodriguez, J.A., Buzaleh, A.M., Fossati, M., Azcurra, J. and Batlle, A., The effects of some porphyrinogenic drugs on the brain cholinergic system. Cell. Mol. Biol. 2002, 48: 103-110.
35. Scherzer, C.R., Landwehrmeyer, G.B., Kerner, J.A., Counihan, T.J., Kosinski, C.M., Standaert, D.G., Daggett, L.P., Velicelebi, G., Penney, J.B. and Young, A.B., Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: Hippocampus and cortex. J. Comp. Neurol. 1998, 390: 75-90. (Pubitemid 28083647)
36. Shanley, B.C., Neathling, A.C., Percy, V.A. and Carstens, M., Neurochemical aspects of porphyria: studies on the possible neurotoxicity of 5-aminolevulinic acid. S. Afr. J. Lab. Clin. Med. 1975, 49: 576-580.
37. Sonntag, W.E., Bennett, S.A., Khan, A.S., Thornton, P.L., Xu, X., Ingram, R.L. and Brunso-Bechtold, J.K., Age and insulin-like growth factor-1 modulate N-methyl-d-aspartate receptor subtype expression in rats. Brain Res. Bull. 2000, 51: 331-338. (Pubitemid 30126025)
38. Tremwel, M.F., Anderson, K.J. and Hunter, B.E., Stability of [3H]MK- 801 binding sites following chronic ethanol consumption. Alcohol. Clin. Exp. Res. 1994, 18: 1004-1008. (Pubitemid 24264127)
39. Trevisan, L., Fitzgerald, L.W., Brose, N., Gasic, G.P., Heinemann, S.F., Duman, R.S. and Nestler, E.J., Chronic ingestion of ethanol up-regulates NMDAR1 receptor subunit immunoreactivity in rat hippocampus. J. Neurochem. 1994, 62: 1635-1638. (Pubitemid 24098118)
40. Tsai, G. and Coyle, J.T., The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu. Rev. Med. 1998, 49: 173-184. (Pubitemid 28197448)
41. Ulrichsen, J., Bech, B., Ebert, B., Diemer, N.H., Allerup, P. and Hemmingsen, R., Glutamate and benzodiazepine receptor autoradiography in rat brain after repetition of alcohol dependence. Psychopharmacology 1996, 126: 31-41. (Pubitemid 26238496)
42. Villayandre, B.M., Paniagua, M.A., Fernández-López, A. and Calvo, P., Effect of delta-aminolevulinic acid treatment on N-methyl-D-aspartate receptor at different ages in the rat brain. Brain Res. 2005, 1061: 80-87 (Pubitemid 41587915)
43. Wong, E.H., Kemp, J.A., Priestley, T., Knight, A.R., Woodruff, G.N. and Iversen, L., The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA. 1986, 83: 7104-7108. (Pubitemid 16002378)